A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma. [electronic resource]
Producer: 19960801Description: 2157-63 p. digitalISSN:- 0959-8049
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Aged
- Antibiotics, Antineoplastic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Drug Therapy, Combination
- Epirubicin -- therapeutic use
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Lenograstim
- Leukocyte Count
- Lymphoma -- drug therapy
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Neutropenia -- drug therapy
- Recombinant Proteins -- administration & dosage
- Single-Blind Method
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.